Skip to main content

Table 2 Relationship of serum fibrosis biomarkers with demographic T1 mapping data

From: Extracellular volume(ECV) quantified by T1 mapping could reflect effect of long term blood pressure control status in patients with essential hypertension

  PICP     ICTP   PICP/ICTP    
  r P value β P value r P value r P value β P value
Age, yrs 0.20 0.11    0.14 0.26 0.10 0.44   
BMI, kg/m2 0.01 0.94    0.14 0.29 0.23 0.07   
SBP, mmHg 0.15 0.25    0.18 0.16 0.25* 0.04 -0.19 0.32
DBP, mmHg 0.28* 0.03 0.11 0.46 0.17 0.18 0.27* 0.03 0.36 0.06
LVEF, % 0.20 0.12    0.16 0.23 -0.16 0.20   
LV mass, g 0.18 0.15    0.28* 0.03 -0.07 0.68   
IVS, mm 0.27* 0.03 -0.05 0.78 0.04 0.80 0.24 0.06   
Native T1 time, msec 0.16 0.21    0.01 0.92 0.16 0.20   
Post-contrast T1 time, msec 0.05 0.67    -0.08 0.53 0.10 0.42   
ECV, % 0.4* 0.01 0.37* 0.02 0.07 0.60 0.37* 0.003 0.30* 0.03
  1. Values are mean ± SD.
  2. PICP: carboxy-terminal propeptide of procollagen type I; ICTP: carboxy-terminal telopeptide of collagen type I; BMI = body mass index; SBP = systolic blood pressure, DBP = diastolic blood pressure; LVEF = left ventricular ejection fraction; IVS = interventricular septum; ECV = extracellular volume fraction.
  3. * p <0.05.